Breast Cancer Clinical Trial

Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions

Summary

The purpose of this retrospective observational study is to evaluate the performance of the Shared Decision Making Process scale in a sample of patients who have received a decision aid about the decision to screen or not screen for breast cancer, colon cancer, prostate cancer, or lung cancer.

View Full Description

Full Description

This is a retrospective observational study that will examine the performance of the Shared Decision Making Process in a sample of patients who made a decision about cancer screening in the last 2 years. Patients from 4 hospitals who have received a patient decision aid for breast, colon, prostate, or lung cancer screening will be screened for eligibility. A random sample of eligible patients will be sent a one-time survey. The survey asks patients about their experiences talking with healthcare providers about the specific cancer screening decision. The survey includes the Shared Decision Making Process scale, knowledge, preferences, decisional conflict and decision regret. The study will obtain 400 completed surveys, or 100 for each cancer topic.

The sample consists of patients who received a decision aid for cancer screening within the last two years and meet specific qualifications.

All analyses will be conducted separately for each group, and results may be pooled. First, study staff examine the descriptives for the Shared Decision Making Process items. Study staff will also test several hypotheses to examine performance of the scores such as whether higher shared decision making process scores are associated with less decisional conflict and less regret.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Breast Cancer group

Female sex
Between ages of 35-55
No previous diagnosis of breast cancer

Colon Cancer Group

Between ages of 45-75
No previous diagnosis of colon cancer

Prostate Cancer Group

Male sex
Between ages of 45-74
No previous diagnosis of prostate cancer

Lung Cancer Group

Between ages of 50-80
No previous diagnosis of lung cancer

Exclusion Criteria:

Breast Cancer group

Unable to confirm primary language is English
History of breast cancer
Severe cognitive impairment who cannot consent for themselves

Colon Cancer Group

Unable to confirm primary language is English
History of colon cancer
Severe cognitive impairment who cannot consent for themselves

Prostate Cancer Group

Unable to confirm primary language is English
History of prostate cancer
Severe cognitive impairment who cannot consent for themselves

Lung Cancer Group

Unable to confirm primary language is English
History of lung cancer
Severe cognitive impairment who cannot consent for themselves

Study is for people with:

Breast Cancer

Estimated Enrollment:

240

Study ID:

NCT04601272

Recruitment Status:

Completed

Sponsor:

Massachusetts General Hospital

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Massachusetts General Hospital
Boston Massachusetts, 02114, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

240

Study ID:

NCT04601272

Recruitment Status:

Completed

Sponsor:


Massachusetts General Hospital

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider